West Pharmaceutical Services Inc

WST: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|bJLOCK|P<vLOCK|<&>JFXJh

West Pharmaceutical Earnings: Getting Back on Track Thanks to Solid Margin Improvement

West reported organic revenue growth of 3% and adjusted diluted earnings per share growth of 12% for the fourth quarter. Guidance for 2026 is 6% organic revenue growth and 10% adjusted diluted EPS growth at the midpoint. Shares are down 5% as of this writing.

Sponsor Center